NCT06068153 2024-11-20
AMBER
ETOP IBCSG Partners Foundation
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT05815186 2024-03-29
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
NYU Langone Health
Phase 2 Withdrawn
NCT05180422 2023-10-18
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis
Criterium, Inc.
Phase 1/2 Withdrawn
NCT05400577 2023-07-17
Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC
Fox Chase Cancer Center
Phase 2 Withdrawn